Table 1 Demographic and clinical characteristics of participants.

Age^a, years (range)

34.35 ± 10.89 (17–60)

41.60 ± 12.43 (18–57)

34.40 ± 11.63 (20–60)

34.18 ± 13.67 (18–60)

35.50 ± 12.38 (16–56)

35.60 ± 12.90 (20–57)

1.593

0.165

Gender^b, male/female, n (total N)

15/19 (N = 34)

5/25 (N = 30)

14/16 (N = 30)

11/11 (N = 22)

15/15 (N = 30)

16/14 (N = 30)

10.940

0.053

BMI^a, kg/m²

22.32 ± 2.85

22.06 ± 2.59

22.71 ± 3.42

24.10 ± 4.05

22.48 ± 2.76

22.89 ± 1.02

1.529

0.183

Education^a, years

10.62 ± 3.31

12.07 ± 3.50

12.07 ± 3.02

10.73 ± 4.21

12.77 ± 2.92

11.67 ± 3.66

1.755

0.125

Marital status^b

3.555

0.615

  Single, n

15

5

9

8

7

10

  Married, n

15

24

19

12

20

18

  Divorce/widow, n

4

1

2

2

3

2

Family history of psychosis^b, yes/no

14/20

3/27

6/24

9/13

2/28

0/30

28.782

 < 0.001**

Duration of illness^a, years

6.06 ± 6.16

2.78 ± 2.95

10.44 ± 9.91

9.25 ± 8.72

1.73 ± 3.11

—

9.513

 < 0.001**

Drug-free, n

34

30

30

15

22

30

Drug

—

—

—

7

8

—

  Antidepressants, n

—

—

—

5

6

—

  Valproate/Lithium, n

—

—

-

7

—

—

  Antipsychotics, n

—

—

—

4

—

—

  Benzodiazepines, n

—

—

—

3

8

—

SAPS total score

42.59 ± 11.06

—

—

—

—

0.37 ± 0.67

SAPS comprehensive evaluation score

12.29 ± 2.71

—

—

—

—

0.27 ± 0.45

HARS score

—

—

—

—

17.37 ± 6.12

0.83 ± 0.87

HDRS score

—

24.07 ± 4.32

—

22.00 ± 4.54

—

1.40 ± 0.82

YMRS score

—

—

32.00 ± 10.43

—

—

0.67 ± 0.71

PDSS score

—

—

—

—

12.70 ± 4.53

0.70 ± 0.70